AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (9.7 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Open Access

Aortic disease and peripheral artery disease

The Writing Committee of the Report on Cardiovascular Health and Diseases in China
Show Author Information

Abstract

The Annual Report on Cardiovascular Health and Diseases in China (2022) intricate landscape of car-diovascular health in China. In connection with the previous section, this 10th section of the report offers a comprehensive analysis of aortic disease and peripheral artery disease. Aortic dissection is a critical disease, with a higher incidence in men than in women. The main risk factors include hypertension, gene mutations, and so on. Recent studies suggest that young patients with aortic dissection have a higher body mass index, and there is a significant correlation between low ambient temperature and sudden temperature drop and the onset of dissection. The main hazards are aortic rupture or poor branch perfusion, which is life threatening. According to the lesion location, it is divided into Stanford A type (involving the ascending aorta) and Stanford B type (not involving the ascending aorta). The treatment of type A dissection is mainly open surgery, while the treatment of type B dissection is preferably endovascular treatment. In recent years, with the continuous development of endovascular technique, the treatment of aortic arch lesions has transformed gradually from open to hybrid, and then to total endovascular treatment. The prevalence of abdominal aortic aneurysm is relatively low (< 1%), and its risk factors mainly include smoking, hypertension, dyslipidemia, etc. The main hazard is the rupture of the aneurysm leading to death. Currently, treatment methods include endovascular repair and open surgery. According to data from Hospital Quality Monitoring System (HQMS), in the past five years, the number of open and endovascular operations for aortic disease in China has shown an upward trend, which may be due to the popularization of diagnostic and therapeutic techniques and increased attention to aortic disease. The in-hospital mortality rates of thoracic endovascular aortic repair, endovascular aortic repair, and Bentall operations are relatively low (all < 2%). Due to the complexity and difficulty of the operation, the in-hospital mortality of total arch replacement is 5.9%–7.4%. Overall, the in-hospital mortality decreased while the number of surgeries increased. This section also elaborates on the five peripheral artery diseases (PADs): lower extremity artery disease (LEAD), carotid atherosclerotic disease, subclavian artery stenosis, mesenteric artery disease and renal artery stenosis, from the perspectives of epidemiology, risk factors, evaluation methods, diagnosis, and treatment. PAD is common among middle-aged and elderly people, and is significantly related to the risk factors of cardiovascular disease. Diagnosis and treatment methods are constantly being improved and updated. Besides traditional evaluation methods, artificial intelligence, molecular biology and other methods have been continuously developed, improving diagnostic sensitivity and specificity. Treatment methods include risk factor control, medication, revascularization (percutaneous endovascular intervention and surgical treatment), and exercise etc. New treatment methods such as cell engineering and xenogeneic vascular graft have also shown promise in the treatment of LEAD.

References

[1]

Tang X, Lu K, Liu XF, et al. Incidence and survival of aortic dissection in urban China: Results from the National Insurance Claims for Epidemiological Research (NICER) study. Lancet Reg Health West Pac 2021; 17: 100280.

[2]

Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000; 283: 897−903.

[3]

Wang WG, Duan WX, Xue Y, et al. Clinical features of acute aortic dissection from the Registry of Aortic Dissection in China. J Thorac Cardiovasc Surg 2014; 148: 2995−3000.

[4]
Wu YD, Gu XY, He YH, et al. [Clinical characteristics and temporal trends of hospitalized patients with aortic dissection from 2002 to 2018: a single-center retrospective analysis]. Zhongguo Xunzheng Xinxueguan Yixue Zazhi 2020; 12: 576–578. [Article in Chinese].
[5]

Xia LT, Huang L, Feng X, et al. Chronobiological patterns of acute aortic dissection in central China. Heart 2020; 107: 320−325.

[6]
Wu S, Cao CH, Lun Y, et al. Age-related differences in acute aortic dissection. J Vasc Surg 2022; 75: 473–483. e4.
[7]

Wu JL, Zhang L, Qiu JT, et al. Morphological features of the thoracic aorta and supra-aortic branches in patients with acute Type A aortic dissection in China. Interact Cardiovasc Thorac Surg 2018; 27: 555−560.

[8]
National Cardiovascular Disease Expert Committee Vascular Surgery Professional Committee. [Expert consensus on genetic testing and clinical diagnosis and treatment of hereditary thoracic aortic aneurysm/dissection]. Zhongguo Xunhuan Zazhi 2019; 34: 319–325. [Article in Chinese].
[9]

Chen JM, Gao Y, Jiang YX, et al. Low ambient temperature and temperature drop between neighbouring days and acute aortic dissection: a case-crossover study. Eur Heart J 2022; 43: 228−235.

[10]
Li Y, Liu SQ, Duan WX, et al. [Analysis of clinical characteristics of acute aortic dissection]. Zhongguo Xunzheng Xinxueguan Yixue Zazhi 2013: 588–592, 614. [Article in Chinese].
[11]
Tao LL, Li F, Mao L, et al. [New progress in early diagnosis of acute aortic dissection]. Zhongwai Yiliao 2020; 39: 196–198. [Article in Chinese].
[12]

Wang Y, Tan X, Gao H, et al. Magnitude of soluble ST2 as a novel biomarker for acute aortic dissection. Circulation 2018; 137: 259−269.

[13]
Chen J, He J. [Retrospective analysis of risk factors for in-hospital death in patients with aortic dissection over 18 years]. Zhongguo Quanke Yixue 2020; 23: 4091–4095. [Article in Chinese].
[14]

Duan WX, Wang WG, Xia L, et al. Clinical profiles and outcomes of acute type A aortic dissection and intramural hematoma in the current era: lessons from the first registry of aortic dissection in China. Chin Med J (Engl) 2021; 134: 927−934.

[15]
Sun LZ, Dong SB. [Status and significance of type A aortic dissection diagnosis and treatment in Chinese aortic surgery]. Zhongguo Xinxueguan Bing Yanjiu 2019; 17: 769–772. [Article in Chinese].
[16]

Shu C, Fan B, Luo MY, et al. Endovascular treatment for aortic arch pathologies: chimney, on-the-table fenestration, and in-situ fenestration techniques. J Thorac Dis 2020; 12: 1437−1448.

[17]

Luo MY, Fang K, Fan BW, et al. Midterm results of retrograde in situ needle fenestration during thoracic endovascular aortic repair of aortic arch pathologies. J Endovasc Ther 2021; 28: 36−43.

[18]

Fang K, Shu C, Luo MY, et al. First-in-man implantation of gutter-free design chimney stent-graft for aortic arch pathology. Ann Thorac Surg 2020; 110: 664−669.

[19]

Jing ZP, Lu QS, Feng JX, et al. Endovascular repair of aortic dissection involving the left subclavian artery by castor stent graft: A multicentre prospective trial. Eur J Vasc Endovas Surg 2020; 60: 854−861.

[20]
Guo W, Zhang HP, Liu XP, et al. Endovascular repair of aortic arch aneurysm with a new modular double inner branch stent graft. Ann Vasc Surg 2020; S0890–5096(20)30468-4.
[21]
National Cardiovascular Disease Expert Committee Vascular Surgery Professional Committee. [Chinese expert consensus on hybrid technique for aortic arch pathology]. Zhongguo Yixue Qianyan Zazhi (Electronic Edition) 2020; 12: 18–24. [Article in Chinese].
[22]

Li K, Zhang KW, Li TX, et al. Primary results of abdominal aortic aneurysm screening in the at-risk residents in middle China. BMC Cardiovasc Disord 2018; 18: 60.

[23]
Jiang B, Li XT, Zhang DM, et al. [Preliminary results of abdominal aortic aneurysm ultrasound screening in Northeast China]. Zhonghua Xiangguan Waike Zazhi 2019; 4: 20–24. [Article in Chinese].
[24]
Zuo SW, Wei YQ, Chen F, et al. [Case-control study on risk factors of abdominal aortic aneurysm]. Beijing Daxue Xuebao (Yixue Ban) 2014: 412–416. [Article in Chinese].
[25]

Fan YN, Ke X, Yi ZL, et al. Plasma D-dimer as a predictor of intraluminal thrombus burden and progression of abdominal aortic aneurysm. Life Sci 2020; 240: 117069.

[26]

Zhu C, Leach JR, Wang Y, et al. Intraluminal thrombus predicts rapid growth of abdominal aortic aneurysms. Radiology 2020; 294: 707−713.

[27]

Yang P, Cai Z, Wu K, et al. Identification of key microRNAs and genes associated with abdominal aortic aneurysm based on the gene expression profile. Exp Physiol 2020; 105: 160−173.

[28]

Huang TT, Liu S, Huang JH, et al. Meta-analysis of the growth rates of abdominal aortic aneurysm in the Chinese population. BMC Cardiovasc Disord 2019; 19: 204.

[29]
Wang R, Yao C, Wang JS, et al. [Analysis of mid-long term efficacy of endovascular repair for abdominal aortic aneurysm: ten-year results from a single center]. Zhonghua Waike Zazhi 2020; 58: E006. [Article in Chinese].
[30]

Shi F, He YC, Wang SY, et al. Endovascular and open surgical repair of abdominal aortic aneurysms: A comparative analysis of Western and Chinese studies. Rev Cardiovasc Med 2020; 21: 75−92.

[31]

Wang ZW, Wang X, Hao G, et al. A national study of the prevalence and risk factors associated with peripheral arterial disease from China: The China Hypertension Survey, 2012–2015. Int J Cardiol 2019; 275: 165−170.

[32]

Zhang XM, Ran XW, Xu ZR, et al. Epidemiological characteristics of lower extremity arterial disease in Chinese diabetes patients at high risk: a prospective, multicenter, cross-sectional study. J Diabetes Complications 2018; 32: 150−156.

[33]
Guan H, Liu ZM, Li GW, et al. [Analysis of related factors of peripheral arterial occlusive disease in diabetic population over 50 years old]. Zhonghua Yixue Zazhi 2007; 87: 23–27. [Article in Chinese].
[34]

Sun J, Deng Q, Wang J, et al. Novel insight into long-term risk of major adverse cardiovascular and cerebrovascular events following lower extremity arteriosclerosis obliterans. Front Cardiovasc Med 2022; 9: 853583.

[35]

Li X, Luo Y, Xu Y, et al. Relationship of ankle-brachial index with all-cause mortality and cardiovascular mortality after a 3-year follow-up: the China ankle-brachial index cohort study. J Hum Hypertens 2010; 24: 111−116.

[36]
Zhang X, Xu Y, Li F, et al. Associations between bone mineral density and subclinical peripheral arterial disease in elderly men with type 2 diabetes mellitus. Osteoporos Int 2022.
[37]

Song PG, Rudan D, Wang M, et al. National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: a systematic review and meta-analysis. J Glob Health 2019; 9: 010601.

[38]

Lu LY, Jiang CQ, Mackay DF, et al. Exposure to secondhand smoke and risk of peripheral arterial disease in southern Chinese non-smokers: The Guangzhou Biobank Cohort Study-Cardiovascular Disease Sub-cohort. Vascular 2017; 25: 283−289.

[39]

Gao JM, Ren ZH, Pan X, et al. Identifying peripheral arterial disease in the elderly patients using machine-learning algorithms. Aging Clin Exp Res 2022; 34: 679−685.

[40]
Ma TY, Gu YQ, Guo LR, et al. [Comparison of surgical methods and prognosis for lower extremity arteriosclerosis obliterans: ten years experience from a single center]. Zhonghua Waike Zazhi 2015; 53: 305–309. [Article in Chinese].
[41]
Jiang XL, Ju S, Chen B, et al. [Analysis of 101 cases of volume reduction surgery for lower extremity arterial disease]. Zhonghua Waike Zazhi 2021; 59: 969–974. [Article in Chinese].
[42]
Su Z, Li Y, Yang S, et al. Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of femoropopliteal arteriosclerosis obliterans. Ann R Coll Surg Engl 2022.
[43]
Gu YQ, Cui SJ, Liu CJ, et al. pUDK-HGF gene therapy to relieve CLI rest pain and ulcer: A phase II, double-blind, randomized placebo-controlled trial. Hum Gene Ther 2021. DOI: 10.1089/hum.2020.290.
[44]
Wang YQ, Li LJ, Li Y, et al. The impact of dietary diversity, lifestyle, and blood lipids on carotid atherosclerosis: A cross-sectional study. Nutrients 2022; 14.
[45]
Zhang L, Zhao JY, Fan L, et al. [Study on the correlation between visceral adiposity index, lipid accumulation index and carotid atherosclerosis in high-risk stroke population]. Zhongguo Dongmai Yinghua Zazhi 2021; 29: 240–246. [Article in Chinese].
[46]
Zhao XH, Hippe DS, Li R, et al. Prevalence and characteristics of carotid artery high-risk atherosclerotic plaques in Chinese patients with cerebrovascular symptoms: A Chinese Atherosclerosis Risk Evaluation II Study. J Am Heart Assoc 2017; 6.
[47]
Wang XJ. Study on epidemiological characteristics of carotid atherosclerosis and its relationship with cardiovascular disease in Chinese population aged 40 and above [dissertation]. Huazhong University of Science and Technology 2018: 1–165.
[48]
Shang J, Li W, Xu FY, et al. [Ultrasound evaluation of carotid atherosclerosis in population aged 45 and above in Dongying area]. Zhongguo Dongmai Yinghua Zazhi 2017; 25: 293–296. [Article in Chinese].
[49]

Zhang K, Lin QX, Zhang TY, et al. Contemporary prevalence and risk factors of carotid artery stenosis in asymptomatic low-income Chinese individuals: a population-based study. Postgrad Med 2020; 132: 650−656.

[50]
Wang XJ, Li WZ, Song FJ, et al. Carotid atherosclerosis detected by ultrasonography: A national cross-sectional study. J Am Heart Assoc 2018; 7.
[51]

Zhang RY, Zhang QW, Ji AH, et al. Identification of high-risk carotid plaque with MRI-based radiomics and machine learning. Eur Radiol 2021; 31: 3116−3126.

[52]

Li BL, Lai XY, Yan CJ, et al. The associations between neutrophil-to-lymphocyte ratio and the Chinese Visceral Adiposity Index, and carotid atherosclerosis and atherosclerotic cardiovascular disease risk. Exp Gerontol 2020; 139: 111019.

[53]

Xiao Q, Hou RY, Li H, et al. Circulating exosomal circRNAs contribute to potential diagnostic value of large artery atherosclerotic stroke. Front Immunol 2021; 12: 830018.

[54]

Li W, Zhao JQ, Song L, et al. Combined effects of carotid plaques and hypertension on the risk of cardiovascular disease and all-cause mortality. Clin Cardiol 2020; 43: 715−722.

[55]
Writing Group of "China Stroke Prevention and Treatment Report". [Summary of "China Stroke Prevention and Treatment Report 2019"]. Zhongguo Naoxueguan Bing Zazhi 2020; 17: 272–281. [Article in Chinese].
[56]
Wang LD, Peng B, Zhang HQ, et al. [Summary of "China Stroke Prevention and Treatment Report 2020"]. Zhongguo Naoxueguan Bing Zazhi 2022; 19: 136–144. [Article in Chinese].
[57]

Sheng CS, Liu M, Zeng WF, et al. Four-limb blood pressure as predictors of mortality in elderly Chinese. Hypertension 2013; 61: 1155−1160.

[58]
Che WQ, Jiang XJ, Dong H, et al. [Etiology and anatomical characteristics of subclavian artery stenosis: analysis of 1793 patients in Fuwai Hospital over 18 years]. Zhongguo Xunhuan Zazhi 2018; 33: 1197–1202. [Article in Chinese].
[59]

Zhang J, Wang LJ, Chen Y, et al. Color doppler ultrasonography for the evaluation of subclavian artery stenosis. Front Neurol 2022; 13: 804039.

[60]
Tong Z, Gu YQ, Guo LR, et al. [Endovascular treatment of complex subclavian artery occlusive disease]. Jieru Fangshe Xue Zazhi 2015; 24: 188–192. [Article in Chinese].
[61]

Niu GC, Yan ZG, Zhang BR, et al. Endovascular treatment of chronic total occlusion in the subclavian artery: A review of 23 cases. Front Neurol 2020; 11: 264.

[62]
Yu HX, Zhang J, Wang ZH, et al. [Analysis of 30 cases of arterial bypass grafting for subclavian artery occlusion]. Zhonghua Putong Waike Zazhi 2005: 271–273. [Article in Chinese].
[63]
Xu CS, Liu WG, Ye W. [Meta-analysis of mesenteric arterial embolism and thrombosis]. Zhonghua Weichangwaike Zazhi 2007: 524–527. [Article in Chinese].
[64]
Sun DL, Zhang ZY, Zhang YS, et al. [Meta-analysis of misdiagnosis of ischemic bowel disease in major Chinese literature in recent 10 years]. Linchuang Wuzhen Wuzhi 2009; 22: 68–70. [Article in Chinese].
[65]
Wen H, Ye K, Qian B, et al. [Predictive factors and clinical value of intestinal necrosis in mesenteric arterial ischemic disease]. Nanjing Yike Daxue Xuebao (Ziran Kexue Ban) 2021; 41: 386–390. [Article in Chinese].
[66]
Liu WH, Shi H, Liao L, et al. [Clinical analysis of 43 cases of acute superior mesenteric artery embolism confirmed by surgery and angiography]. Zhonghua Neike Zazhi 2014; 53: 375–379. [Article in Chinese].
[67]

Zhang Z, Wang D, Li GX, et al. Endovascular treatment for acute thromboembolic occlusion of the superior mesenteric artery and the outcome comparison between endovascular and open surgical treatments: A retrospective study. Biomed Res Int 2017; 2017: 1964765.

[68]

Li WR, Cao SS, Zhang ZW, et al. Outcome comparison of endovascular and open surgery for the treatment of acute superior mesenteric artery embolism: A retrospective study. Front Surg 2022; 9: 833464.

[69]
Li NF, Wang L, Zhou KM, et al. [Characteristics of etiology composition in hospitalized hypertensive patients in People's Hospital of Xinjiang Uygur Autonomous Region]. Zhonghua Xinxueguanbing Zazhi 2007; 35: 865–868. [Article in Chinese].
[70]

Fang CC, Chen WJ, Peng CL, et al. Renovascular disease in Taiwan: a long-term nationwide population study. Int J Cardiol 2013; 168: 541−542.

[71]
Yan JH, Sun LX, Zhao XY, et al. [Analysis of prevalence and risk factors of atherosclerotic renal artery stenosis]. Zhonghua Yixue Zazhi 2013; 93: 827–831. [Article in Chinese].
[72]

Dong HJ, Ou YQ, Nie ZQ, et al. Association of renal artery stenosis with left ventricular remodeling in patients coexisting with renovascular and coronary artery disease. Vascular 2019; 27: 190−198.

[73]

Zheng B, Ma Q, Zheng LH, et al. Analysis of renal artery stenosis in patients with heart failure: A RASHEF study. Chin Med J (Engl) 2015; 128: 2777−2782.

[74]

Xiong HL, Peng M, Jiang XJ, et al. Time trends regarding the etiology of renal artery stenosis: 18 years' experience from the China Center for Cardiovascular Disease. J Clin Hypertens (Greenwich) 2018; 20: 1302−1309.

[75]

Li TH, Mao YH, Zhao B, et al. Value of contrast-enhanced ultrasound for diagnosis and follow-up of renal artery stenosis in patients with chronic kidney disease. Abdom Radiol (NY) 2022; 47: 1853−1861.

[76]

Cui YH, Zhang QB, Yan JP, et al. The value of contrast-enhanced ultrasound versus doppler ultrasound in grading renal artery stenosis. Biomed Res Int 2020; 2020: 7145728.

[77]

Zeng YM, Xu JZ, Chen X, et al. Analysis of the effect of percutaneous renal artery stenting on atherosclerotic unilateral renal artery stenosis based on split glomerular filtration rate evaluation. Jieru Fangshexue Zazhi 2021; 30: 1003−1005.

[78]

Lin ZY, Zhang BH, Lin LT, et al. Prediction of split renal function improvement after renal artery stenting by blood oxygen level-dependent magnetic resonance imaging. Front Cardiovasc Med 2022; 9: 793777.

[79]

Hu YB, Zhang YG, Wang H, et al. Percutaneous renal artery stent implantation in the treatment of atherosclerotic renal artery stenosis. Exp Ther Med 2018; 16: 2331−2336.

[80]

Tong Z, Xu ZQ, Tong YS, et al. Effectiveness of distal arterial bypass with porcine decellularized vascular graft for treating diabetic lower limb ischemia. Int J Artif Organs 2021; 44: 580−586.

Journal of Geriatric Cardiology
Pages 931-943
Cite this article:
HU S-S. Aortic disease and peripheral artery disease. Journal of Geriatric Cardiology, 2024, 21(10): 931-943. https://doi.org/10.26599/1671-5411.2024.10.008

244

Views

3

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Altmetrics

Published: 28 October 2024
© 2024 JGC All rights reserved
Return